Biểu đồ giá cổ phiếu CADL
CADL Dự đoán giá cổ phiếu
Candel Therapeutics Inc
$8.77
-1.57%
$-0.14
Khi đóng cửa: May 15, 16:00:00 GMT-4
$8.93
1.92%
$0.16
Phiên sau giờ: May 15, 20:00:00 GMT-4
Quay lại
Candel Therapeutics Inc (CADL) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
$8.91
Giá mở cửa
$8.67
Phạm vi ngày
$7.78 - $9.07
Phạm vi 52 tuần
$4.33 - $8.93
Khối lượng
3.6M
Khối lượng trung bình
1.1M
Tỷ suất cổ tức
--
EPS (TTM)
-0.70
Vốn hóa thị trường
$654.7M
CADL là gì?
Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. The company is headquartered in Needham, Massachusetts and currently employs 55 full-time employees. The company went IPO on 2021-07-27. CAN-2409 is the lead product candidate from the adenovirus platform. CAN-3110 is the lead product candidate from the herpes simplex virus (HSV) platform and is in an ongoing phase Ib clinical trial in recurrent high-grade glioma. Its enLIGHTEN Discovery Platform is a systematic, iterative HSV-based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid tumors. CAN-2409, Its advanced multimodal biological immunotherapy candidate, is an investigational, off-the-shelf, replication-defective adenovirus engineered to deliver the herpes simplex virus thymidine kinase (HSV-tk) gene to a patient’s specific tumor and induce an individualized, systemic immune response against the tumor.
